Feedback / Questions
fluorocyclopentenylcytosine (RX-3117) - Rexahn
gemcitabine - generics
http://globenewswire.com/news-release/2019/02/19/1734221/0/en/Rexahn-Presents-Updated-Interim-Data-From-Phase-2a-Trial-of-RX-3117-in-Advanced-Bladder-Cancer-at-the-2019-ASCO-GU-Symposium.html
Feb 24, 2019
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next